KRT19 and hepatocellular carcinoma: In conclusion, ultrasomics signatures could be used for noninvasive prediction of CK19 expression in HCC, and the combined prediction of clinical features and optimal ultrasomics feature subset showed an excellent performance, which improved the prediction of CK19 expression in HCC significantly.